Skip to content

Assessment of liver pathogenesis by MR elastography in chronic liver diseases

Assessment of liver pathogenesis by MR elastography in chronic liver diseases - Assessment of liver pathogenesis by MR elastography in chronic liver diseases(MRELAST STUDY)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012757
Enrollment
100
Registered
2014-01-06
Start date
2014-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic liver diseases

Interventions

None listed

Sponsors

Yokohama City University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are scheduled to undergo liver biopsy or hepatectomy at our institution, provide a written informed consent, and do not meet the below exclusion criteria.

Exclusion criteria

Exclusion criteria: 1. Patients with anti-coagulation therapy 2. MRI examination is impossible (ex. Installation of pacemaker, claustrophobia) 3. Pregnant patients 4. In the opinion of the investigator, patient is unsuitable as a study subject.

Design outcomes

Primary

MeasureTime frame
To assess whether MR elastography is useful for diagnosis of liver inflammation and fibrosis in patients with chronic liver diseases.

Countries

Japan

Contacts

Public ContactKento Imajo

Yokohama City University Graduate School of Medicine Division of Gastroenterology

kento318@yohohama-cu.ac.jp045-787-2640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026